INTRODUCTION
Sulfite oxidase is a molybdo-hemoprotein which serves as the terminal enzyme in the pathway of oxidative degradation of sulfur amino acids. The enzyme has been purified and characterized from bovine (1-3) and chicken livers (4) and extensively studied in the rat in terms of molybdenum metabolism in this species (5) (6) (7) (8) .
In this paper we report the isolation and properties of sulfite oxidase from human liver and the relationship of this enzyme to those from other sources. Particular emphasis will be placed on the comparative properties of the human and rat liver enzymes, since this latter source has recently yielded pure, homogeneous sulfite oxidase, not as yet attained from other species. Characterization of the human enzyme was undertaken in response to well-documented reports of a case of sulfite oxidase deReceived for publication 22 August 1975 and in revised form 28 April 1976. ficiency which was encountered several years ago (9) (10) (11) ; the study has taken on additional significance as the result of identification of a second instance of the deficiency disease.1
METHODS
Normal human liver obtained at autopsy was used immediately or frozen for not more than 1 wk at -20°C before isolation of the enzyme. Male Charles-River rats weighing 250-300 g were obtained from the National Institute of Environmental Health Sciences and maintained on standard laboratory chow and tap water. The rats were killed by decapitation and the livers were excised, rinsed with cold 0.25 M sucrose, and used immediately for enzyme purification.
Sodium sulfite was purchased from Baker and Adamson (Allied Chemical, General Chemical Division, Morristown, N. J.). A 0.1-M solution was prepared and stored frozen in 1-ml portions. Horse heart cytochrome c, type III, purchased from Sigma Chemical Co. (St. Louis, Mo.), was made up as a 1-mM solution in 0.1 M Tris-HCl, pH 8.5 , and stored at 4°C. Freezing and foaming were avoided to prevent the formation of inhibitory polymers (12) . Sulfite oxidase activity was assayed at room temperature by monitoring the reduction of cytochrome c at 550 nm. Cuvettes contained [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Al enzyme, 0.04 mM ferricytochrome c, 0.4 mM sodium sulfite, and 0.1 M Tris buffer, pH 8.5, to a final volume of 2.5 ml. The reaction was started by the addition of sulfite to the assay mixture after the base-line rate of cytochrome c reduction was recorded. A slow nonenzymatic rate of reduction of cytochrome c by sulfite was also noted under these conditions and subtracted from the recorded total rate. In assays of crude homogenates, 0.04% sodium deoxycholate and 0.5 mM sodium cyanide were included in the assay mixture. 1 U of sulfite oxidase activity was defined as the amount of enzyme which produced an absorbance change of 1.0/min under the above conditions. By this definition, 7.6 U correspond to 1 Amol of cytochrome c reduced per minute (13) . Conditions for assay of activity with oxygen and ferricyanide as electron acceptors were as described previously (1) . Activity measurements and absorption spectra were recorded on a Cary 14 spectropho-'Dr. Vivian Shih, Massachusetts General Hospital, Bostoni, Mass. Personal communication.
The Journal of Clinical Investigation Volume 58 September 1976*543-550 The human enzyme profile represents 400 g liver as starting material; the rat enzyme was from 187 g liver. * Activity values for the heat step supernatant reflect some inhibition by sulfate ions carried over into the assay cuvette. This effect is more pronounced in the human liver preparation since larger samples were required for assay. (16) . Gels were stained for protein with amido black. Previously described procedures were used to stain the gels for heme (17) and sulfite oxidase activity (18) . Acrylamide gel electrophoresis in the presence of sodium dodecyl sulfate was carried out according to the method of Weber and Osborn (19) . Urea at a concentration of 6 M was included in the denaturing solution and in the gels to enhance the sharpness of protein bands (20) . The 
RESULTS
Purification of sulfite oxidase from human liver. Human liver sulfite oxidase was purified by a procedure similar to those previously described for bovine (1) , avian (4) , and rat liver (5) sulfite oxidase. The results of a typical purification are shown in Table I . Results obtained during isolation of sulfite oxidase from rat liver are included in the table for comparative purposes. Although the procedures applied for purification of the enzyme from the two sources were identical, the stability of the human enzyme to the various steps which were employed and its relatively strong affinity for DE-52 cellulose proved to be of extreme value in its purification. Thus, even though the specific activity of sulfite oxidase in the human liver was less than 10% of that in rat liver, excellent yield and improved purification ratios, especially on the DE-52 column, allowed isolation of the human enzyme in a state of purity not far removed from the entirely homogeneous nature of the rat liver enzyme. Details of the purification procedure are as follows. dase. To distinguish between these two possibilities, the peak I preparation was reduced with dithionite and the a-band of the cytochrome spectrum was examined in detail. As seen in the inset to Fig. 2 , the reduced spectrum shows an asymmetric a band with a maximum at 556 nm and a shoulder at about 560 nm. Identical spectral properties have been reported for rat liver microsomal cytochrome b5 by Ito (24) . In contrast, the rat liver mitochondrial small cytochrome b5 (24) , native rat liver sulfite oxidase (7, 24) , and native sulfite oxidase from human liver (Fig. 2) show absorption spectra characterized by a symmetrical a band at 557 nm. Thus we can conclude that the early 413 nm peak seen on DE-52 chromatography of the human liver preparation is primarily microsomal cytochrome b5 and not a proteolytic fragment derived from sulfite oxidase. Proteolytic activity in the liver before autopsy and during enzyme isolation was apparently sufficient to release significant amounts of this protein from its membrane locus such that it was recovered in the hypotonic supernatant fraction. The rat liver preparation, where fresh livers were used immediately for enzyme isolation, showed very little or no release of any low molecular weight b5 cytochrome.
A second notable feature of the DE-52 elution profile for human sulfite oxidase is the tightness of the binding of the active enzyme to the column under the ionic conditions applied. Peak activity eluted nearly 20 tubes (200 ml) later than the rat liver enzyme. This would suggest that the human enzyme contains a greater proportion of negatively charged residues than does the rat liver protein.
For further purification, fractions of peak activity from DEAE-cellulose were pooled and concentrated to about 1 ml by ultrafiltration. These solutions were then applied to a column (2.5 X 90 cm) of Sephadex G-200 which had been equilibrated with 0.05 M potassium phosphate, pH 7.8, and then chromatographed with the same buffer. The elution patterns of human and rat liver sulfite oxidases from Sephadex G-200 are shown in Fig. 3 . It can be seen that each enzyme eluted from the column in a symmetrical peak with congruent absorption at 413 and 280 nm. The elution volume for the human enzyme, however, was slightly smaller than that for the rat enzyme, indicative of a slightly larger molecular weight for human sulfite oxidase. The 413/280 nm absorbance ratio of the peak tubes from the rat enzyme profile was 0.94; the highest ratio obtained for human sulfite oxidase was 0.83.
Properties of human liver sulfite oxidase. The results of polyacrylamide gel electrophoresis of human and rat sulfite oxidase preparations are shown in Fig. 4 . Both enzymes produced single bands when stained for heme or sulfite oxidase activity. Homogeneity of the rat preparation was evident from the single protein species seen on the acrylamide gel. Minor protein bands seen on the gel of human sulfite oxidase indicated that this preparation was approximately 90% pure enzyme. The increased mobility of the human enzyme relative to that of the rat enzyme in this gel system is entirely consistent with the behavior on DEAE-cellulose, suggesting that sulfite oxi- FIGURE 4 Acrylamide gel electrophoresis of human (A) and rat liver sulfite oxidases (B). Gels contained 7.5%o polyacrylamide and were stained for protein (1), heme (2), or activity (3). dase from human liver has a higher proportion of negatively charged residues. Acrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (Fig. 5) confirmed the purity of the rat liver preparation and again revealed trace contaminants present with the human liver enzyme. Electrophoresis of a mixture of rat and human sulfite oxidases on a single gel resulted in a clear separation of the two proteins. As shown in Fig. 6 , the subunit -molecular weights of the human and rat enzymes were determined to be 61,100 and 57,200, respectively. The somewhat larger molecular weight of the human enzyme is consistent with its behavior on Sephadex G-200 and indicates that its greater mobility on acrylamide gels run in the absence of sodium dodecyl sulfate is entirely due to an altered charge distribution. The excess negative charges are in fact sufficient to overcome the retarding effect of larger molecular weight and result in increased mobility relative to the rat liver protein. The subunit molecular weights of sulfite oxidases from chicken (4) and bovine livers (2), at 55,000-56,000 daltons, are somewhat smaller even than that of the rat enzyme. Sedimentation studies on the bovine (2) and chicken enzymes (4) tEnzyme activity measurements were made on solutionis with an OD413 l of 0.10)0.
Assay coniditions are described in Miethods. dimeric molecules. Similar elution of enzyme from all four animal sources from Sephadex G-200 allows the conclusion that human and rat liver sulfite oxidases are each composed of two identical subunits, and thus have native molecular weights of about 122,000 and 114,400, respectively.
Absorption spectra of human and rat liver sulfite oxidases are shown in Fig. 7 . The two preparations display remarkably similar spectral properties, particularly in features characteristic of the b5 prosthetic group. The somewhat higher absorption at 280 nm of the human enzyme probably reflects the slight contamination in this preparation; however, the 413/280 ratio of 0.94 obtained with the rat enzyme is certainly not a criterion of purity for judging the human preparation. Additional aromatic residues could well contribute to the increased molecular wveight of the human sulfite oxidase molecule and thus define a somewhat lower ratio for the pure enzyme. FIGURE 8 Ouchterlony double immunodiffusion of human and rat liver sulfite oxidase preparations. Well 1 contained partially purified rat liver sulfite oxidase (through DEAEcellulose stage) at a concentration of about 300 U/ml. Human liver sulfite oxidase at the same stage of purification was present in wells 2 and 3 at a concentration of 650 U/ml and in wells 4 and 5 at 1,300 U/mI. The center well contained rabbit antibody prepared against purified rat liver sulfite oxidase at a titre of approximately 1,000 U/ml. Diffusion was allowed to proceed for 24 h in a humid atmosphere at room temperature. After formation of precipitin bands the plates were soaked in 0.9% NaCl to remove uncomplexed proteins, washed in distilled water, dried, and stained with amido black.
A careful determination of molybdenum and heme stoichiometry was done on the rat liver sulfite oxidase preparation and related to protein values measured by Lowry et al. (14) and dry weight methods. Protein values obtained by the two methods were in good agreement and were related to the spectral properties of the enzyme such that rat liver sulfite oxidase protein in milligram per milliliter is equal to 0.62 X A413 nm. Cofactor values obtained were 0.75 molybdenum and 0.85 heme per subunit. Purified rat liver sulfite oxidase with such1 a cofactor composition has an activity of 1,320 U/mg measured with cytochrome c as the electron acceptor.
Due to the trace contaminants present in the human liver preparation, Lowry protein or dry weight measurements were not accurate indicators of sulfite oxidase protein. Thus, it became more meaningful to relate molybdenum and activity values to spectral properties of the b5 heme, which have been rigorously conserved in all of the diverse sources so far examined. Molybdenum to heme and activity to heme ratios are shown in Table  II . It can be seen that although the molybdenum content is comparable in the two preparations, the activity of the human enzyme is considerably less than that of the rat enzyme. This observation was seen to apply not only to cytochrome c reduction but to sulfite oxidation with ferricyanide or oxygen as electron acceptors as well.
The great degree of similarity noted between the human and rat sulfite oxidases raised the possibility that the human enzyme might be capable of cross-reacting with an antibody preparation directed against the rat liver enzyme. The Ouchterlony double immunodiffusion plate shown in Fig. 8 provides evidence of considerable cross-reactivity between the two proteins. A strong precipitin band was observed between wells containing human sulfite oxidase and rabbit antirat sulfite oxidase antibody. The spur pattern shows that human and rat enzymes are immunologically related, but not identical, and that the human enzyme possesses some but not all of the determinants recognized on the rat enzyme. Fig. 9 compares quantitative reactivities of human and rat liver sulfite oxidases with the antibody directed against the rat enzyme. As can be seen, 50%, of the activity of the human enzyme was precipitated by serum at about 2 X the concentration required to yield similar results with the rat enzyme. This observation attests to the similarity of the two proteins; the slight difference in titer is of course consistent with somewhat fewer recognized determinants on the human sulfite oxidase protein.
DISCUSSION
Sulfite oxidase has been detected in human autopsy livers at a fairly constant level of 10-25 U/g wet weight of the tissue. This is considerably lower than the level found in an adult rat, 200-250 U/g, or chicken, 100-150 U/g (4) . Bovine liver contains about 50 U/g (1) . The lower specific activity of the human liver enzyme could have posed serious problems in its isolation; however, rather fortuitous behavior at several stages in the purification procedure allowed isolation in good yield and high purity. Two important features in the purification of both rat and human sulfite oxidases not emphasized in the Results should be mentioned. The use of fresh rat livers has been found to be essential for isolation of sulfite oxidase of highest purity. While enzyme activity is undiminished in livers frozen for several months, the properties of the protein are apparently altered such that considerable loss of activity and sulfite oxidase protein are noted at the heat step. Rat or human liver frozen for short periods of time (less than 1 wk), however, will serve as good starting materials for sulfite oxidase purification. A second consideration in preparation of pure sulfite oxidase is speed in isolation. Enzyme prepared by homogenizing livers in the morning should be chromatographed on DE-52 overnight and after spectral analysis, immediately concentrated and applied to Sephadex G-200. Adherence to this protocol results in the isolation of enzyme of reproducible purity.
MIany of the properties of human liver sulfite oxidase have been shown to be identical to those of rat, chicken, and bovine enzymes. The subunit structure and cofactor composition are unaltered in the enzyme from these various sources. The b5 cytochrome is identical in all details, including the symmetrical a peak observed in the spectrum of the reduced chromophore.
Two obvious differences between the rat and human proteins were revealed by gel chromatography techniques. The increased negative charge and slightly larger subunit molecular weight of the human enzyme may reflect evolutionary alterations in the protein structure with no apparent effect on catalytic functionality. A study of the distribution and localization of the additional residues and negative charges, however, would /128 '512 '2048 antibody dilution FIGURE 9 Precipitation of sulfite oxidase from human (*) and rat liver (0) with rabbit antibody directed against rat liver sulfite oxidase. Human and rat liver enzymes were diluted in 0.01 M potassium phosphate, pH 7.8 with 1 mg/ ml bovine serum albumin to an equal heme concentration with absorbance at 413 nm of 0.055. The enzymes were mixed with equal volumes of serial dilutions of antibody in 0.01 M potassium phosphate, and incubated at 0'C for 40 min. After centrifugation at 10,000 g for 10 min, activities remaining in the supernate were assayed. Bovine serum albumin was included in the incubations to insure stability of the enzymes in dilute solution. Conditions employed for antibody complex formation were determined to be optimal for both human and rat enzymes.
be extremely interesting and indeed might reveal an influence on the activity of the enzyme.
The molybdenum center of sulfite oxidase is the vital catalytic center where electrons from sulfite enter the enzyme. The molybdenum centers in the rat (5) and chicken enzymes (4, 25) have been investigated extensively by electron paramagnetic resonance spectroscopy and shown to be uniquely sensitive to alterations in pH and ionic composition of the medium. Similar studies on a crude preparation of human liver sulfite oxidase have been reported previously (4) and have shown that the pH sensitivity of the molybdenum center is clearly conserved in the human enzyme. Thus, application of electron paramagnetic resonance as a sensitive probe of the geometry of paramagnetic molybdenum in sulfite oxidase detected no difference among the enzymes from various species. Identity of the molybdenum centers by this criterion and the near stoichiometric molybdenum contents of both the rat and human enzymes make the lowered activities observed in the human sulfite oxidase preparation especially intriguing. Lower reactivity in the cytochrome c assay immediately suggested a more stringent requirement for intraspecies cytochrome c in the case of the human enzyme. In fact, additional negative charges near the bs heme of the enzyme could disrupt heme-heme interaction required for transfer of electrons to cytochrome c unless the cytochrome c were specifically evolved to recognize the altered surface configuration. However, the lowered reactivities with ferricyanide and oxygen as electron acceptors, which are believed to react with sites on the enzyme other than the heme, make such a postulate unlikely. A more acceptable hypothesis at this point is that in a portion of the human sulfite oxidase molecules as isolated, the molybdenum center is nonfunctional. A careful quantitation of sulfitereducible molybdenum using electron paramagnetic resonance would help to establish whether this is the case.
The cross-reactivity of human sulfite oxidase with the antibody directed against rat enzyme is a particularly important finding. Inhibition of the human enzyme with the available antirat sulfite oxidase antibody preparation provides a convenient and sensitive assay for crossreacting material in tissue samples from sulfite oxidase deficient individuals. The following article (26) describes experiments which investigate in detail the lesion expressed as sulfite oxidase deficiency in one patient. Characterization of human liver sulfite oxidase as reported above is essential groundwork for study of the deficiency disease and has contributed to a better understanding of molybdoenzymes in animal systems.
